Jan 30, 2023
Although the aim of the VPAS scheme is to support innovation and better patient outcomes, alongside keeping a lid on the NHS drug budget, could the scheme actually be doing the opposite? If the rebate is unsustainable, and results in loss making products for...
Jan 30, 2023
We’ve all read the latest from NICE on the revised recommendations for the use of Statins to reduce the risk of cardiovascular events. It’s been widely shared that there are currently 10 million eligible patients in the UK, and this could rise to as many as 25...
Dec 23, 2022
With the recent increase in bacterial infections and the shortage of Strep A antibiotic drugs such as penicillin and amoxicillin, Wavedata thought it worth looking at all the antibiotics used in the community in the UK to see which have experienced the greatest price...
Dec 12, 2022
Branded Procoralan first appeared on price lists sent to pharmacists and dispensing doctors in the UK in February 2008, followed 5 months later in July 2008 by parallel imported versions. The number of offers each month for the parallel import grew slowly to a peak of...
Dec 12, 2022
Branded Ezetrol first appeared on price lists sent to pharmacists and dispensing doctors in the UK in June 2004, accompanied in the same month by the first evidence of parallel imports. However, the number of price list offers for the parallel import has never topped...
Dec 12, 2022
Branded Cialis was launched in the UK March 2003, which was followed in July 2004, 16 months later, by the appearance of the first parallel import. The number of monthly offers for the PI peaked in October 2008 at 137 market offers in a single month. However by June...
